Compounds > farnesol

farnesol and vancomycin

farnesol has been researched along with vancomycin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Agostinho, ÍRC; Araújo, AR; Campos, MAS; de Alcântara Oliveira, FA; de Carvalho Sousa, B; de Oliveira Castelo Branco, RR; Dos Santos Soares, MJ; Gonzalez, AGM; Lopes, AP; Pinheiro, REE; Rocha, JA1
Azeredo, J; Cerca, N; Gomes, F; Leite, B; Oliveira, R; Teixeira, P1
Barrish, J; Hicks, JM; Liang, R; Pammi, M; Versalovic, J1
Cerca, N; Gomes, F; Oliveira, R; Pereira, S; Teixeira, P1
Agrawal, A; Bhattacharyya, S; Ducheyne, P; Knabe, C1
Jabra-Rizk, MA; Kong, EF; Kucharíková, S; Tsui, C; Van Dijck, P1
Bhattacharyya, S; Briggs, T; Ducheyne, P; Knabe, C; Qu, H; Sheth, N; Woelfle, UC1

Other Studies

7 other study(ies) available for farnesol and vancomycin

ArticleYear
Antimicrobial, modulatory, and antibiofilm activity of tt-farnesol on bacterial and fungal strains of importance to human health.
    Bioorganic & medicinal chemistry letters, 2021, 09-01, Volume: 47

    Topics: Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship

2021
Farnesol as antibiotics adjuvant in Staphylococcus epidermidis control in vitro.
    The American journal of the medical sciences, 2011, Volume: 341, Issue:3

    Topics: Anti-Bacterial Agents; Biofilms; Drug Therapy, Combination; Farnesol; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Microbial Viability; Plankton; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Stem Cells; Tetracycline; Time Factors; Vancomycin

2011
Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin.
    Pediatric research, 2011, Volume: 70, Issue:6

    Topics: Animals; Biofilms; Catheter-Related Infections; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Synergism; Farnesol; Inhibitory Concentration 50; Mice; Microscopy, Confocal; Nafcillin; Staphylococcus epidermidis; Vancomycin

2011
Confocal laser scanning microscopy analysis of S. epidermidis biofilms exposed to farnesol, vancomycin and rifampicin.
    BMC research notes, 2012, May-16, Volume: 5

    Topics: Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Farnesol; Fluorescent Dyes; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Confocal; Rifampin; Staphylococcus epidermidis; Vancomycin

2012
Sol-gel silica controlled release thin films for the inhibition of methicillin-resistant Staphylococcus aureus.
    Biomaterials, 2014, Volume: 35, Issue:1

    Topics: Anti-Bacterial Agents; Farnesol; Gels; Hydrophobic and Hydrophilic Interactions; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Silicon Dioxide; Vancomycin

2014
Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Candida albicans; Culture Media, Conditioned; Drug Tolerance; Farnesol; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Microbial Viability; Multidrug Resistance-Associated Proteins; Protein Isoforms; Quorum Sensing; Reactive Oxygen Species; Staphylococcus aureus; Symbiosis; Vancomycin

2017
Dual local drug delivery of vancomycin and farnesol for mitigation of MRSA infection in vivo - a pilot study.
    European cells & materials, 2020, 07-16, Volume: 40

    Topics: Animals; Bone and Bones; Coated Materials, Biocompatible; Drug Delivery Systems; Farnesol; Male; Methicillin-Resistant Staphylococcus aureus; Pilot Projects; Rats, Sprague-Dawley; Staphylococcal Infections; Vancomycin; X-Ray Microtomography

2020